For research use only. Not for therapeutic Use.
NCGC00138783 TFA（Cat No.:I041377）is a small molecule inhibitor developed for research purposes, primarily targeting specific enzymes or proteins involved in disease pathways. As a trifluoroacetate (TFA) salt, it is designed to improve the solubility and stability of the compound for use in laboratory settings. NCGC00138783 TFA has shown potential in preclinical studies for modulating pathways related to cancer, inflammation, and other diseases. Its precise mechanism of action and potential clinical applications are still under investigation, with ongoing research focused on its efficacy and possible therapeutic uses in drug development.
| Synonyms | 2-[[2-[2-(3,5-dimethyl-1H-pyrazol-4-yl)ethyl]-[1,2,4]triazolo[1,5-c]quinazolin-5-yl]sulfanyl]-N-(4-fluorophenyl)butanamide;2,2,2-trifluoroacetic acid |
| Molecular Formula | C28H27F4N7O3S |
| Purity | ≥95% |
| IUPAC Name | 2-[[2-[2-(3,5-dimethyl-1H-pyrazol-4-yl)ethyl]-[1,2,4]triazolo[1,5-c]quinazolin-5-yl]sulfanyl]-N-(4-fluorophenyl)butanamide;2,2,2-trifluoroacetic acid |
| InChI | InChI=1S/C26H26FN7OS.C2HF3O2/c1-4-22(25(35)28-18-11-9-17(27)10-12-18)36-26-29-21-8-6-5-7-20(21)24-30-23(33-34(24)26)14-13-19-15(2)31-32-16(19)3;3-2(4,5)1(6)7/h5-12,22H,4,13-14H2,1-3H3,(H,28,35)(H,31,32);(H,6,7) |
| InChIKey | JJJTWAPHLDVONC-UHFFFAOYSA-N |
| SMILES | CCC(C(=O)NC1=CC=C(C=C1)F)SC2=NC3=CC=CC=C3C4=NC(=NN42)CCC5=C(NN=C5C)C.C(=O)(C(F)(F)F)O |
